A Study to Find Out if Daridorexant is Safe and Efficacious in Patients With Insomnia and Comorbid Nocturia
Part of paid clinical trials in Miami Beach, Florida.
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Study ID
- NCT05597020
- Phase
- PHASE4
- Status
- Completed
Conditions
- Insomnia Disorder
- Nocturia
Eligibility Criteria
- Sex
- ALL
- Age
- 55 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Daridorexant — DRUGDaridorexant is available as oral film-coated tablets at a strength of 50 mg.
- Placebo — DRUGPlacebo matching daridorexant is provided as identical-looking oral tablets, formulated with the same inactive ingredients (excipients) as the active tablets.
Study Details
A study to find out if daridorexant is safe and efficacious in patients with insomnia and comorbid nocturia
Key Dates
- Start date
- Feb 16, 2023
- Status verified
- Apr 2025
- Primary completion
- Apr 12, 2024
- Completion
- Apr 18, 2024
Study Design
- Enrollment
- 60 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- TREATMENT
Arms
- Experimental: 50 mg daridorexantDaridorexant will be taken orally, once daily in the evening within approximately 30 min before going to bed.
- Placebo Comparator: PlaceboMatching placebo will be taken orally, once daily in the evening within approximately 30 min before going to bed.
Primary Outcome Measure
Change From Baseline to Week 4 in sTST [ Time Frame: From baseline to Week 4 per treatment period. ]
Locations (5)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Quantum Clinical Trials | Miami Beach | Florida | 33140 | - |
| Clinical Research Center of Florida | Pompano Beach | Florida | 33060 | - |
| Encore Medical Research of Weston | Weston | Florida | 33331 | - |
| Ochsner LSU Health Shreveport-Regional Urology | Shreveport | Louisiana | 71106 | - |
| Accellacare Research of Cary | Cary | North Carolina | 27518 | - |
Find similar trials in Miami Beach, FL
Related Studies
- Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin APHASE4 · Recruiting · University of South Florida · Washington D.C., District of Columbia
- APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in WomenRecruiting · Medstar Health Research Institute · Birmingham, Alabama
- Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric InsomniaPHASE3 · Recruiting · Vanda Pharmaceuticals · Dothan, Alabama
- Brief Behavioral Treatment for Insomnia in Veterans With Posttraumatic Stress DisorderRecruiting · VA Office of Research and Development · San Francisco, California